About Us

From small steps as Australia’s first producer of cannabis medicine, Little Green Pharma has achieved major strides in only a short time. But this is only the beginning of our journey with significant growth anticipated in highly lucrative global markets.

Starting life back in 2017 with just one small grow room and a handful of plants, our commitment was on proving and perfecting the process.  Our purpose from the outset was clear: to make a world of difference for our patients.

Jump ahead six years, and we are a leader in Australia with one of the most trusted brands in the country. We have built robust market share and have been consistently growing our sales and revenue. Throughout this process, we have run a tight ship, keeping our costs to a minimum while ensuring top quality results.

Having clearly demonstrated our success in Australia, we have set our sights on highly lucrative European markets.

Europe is the biggest market outside of North America, and with twice the population and a rapidly maturing approach to medicinal cannabis there is enormous potential for growth.

We were the first company to export Australian cannabis medicines starting with the UK in 2020 and then expanding into Germany and other European countries.

We took our next big step in 2021 with the purchase of a cultivation and manufacturing facility in Denmark, one of the largest medicinal cannabis manufacturing sites in Europe.

Our footprint in Europe has given us a competitive advantage over other non-European medicinal cannabis companies.

We have supply arrangements with nine distributors across Europe, giving us access to 380 million people or 76% of EU and UK citizens.

Importantly, more countries in Europe are legalising medicinal cannabis use. We have the building blocks in place to supply product to these markets.

With a proven track record and huge growth opportunities, we’re ready to rapidly accelerate delivery of large volumes across Europe.

We’re making a world of difference ... to the whole world.

Fleta Solomon, CEO
January 2023

Click here to view presentation